Kelly Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-631
Closed -$48.6K 196
2024
Q2
$48.6K Hold
631
0.02% 229
2024
Q1
$43.2K Hold
631
0.02% 238
2023
Q4
$36.5K Hold
631
0.01% 236
2023
Q3
$33.3K Hold
631
0.02% 227
2023
Q2
$34.1K Hold
631
0.02% 231
2023
Q1
$31.6K Hold
631
0.02% 229
2022
Q4
$29.2K Hold
631
0.02% 226
2022
Q3
$24.4K Hold
631
0.01% 233
2022
Q2
$23.5K Hold
631
0.01% 236
2022
Q1
$27.9K Hold
631
0.01% 244
2021
Q4
$26.8K Hold
631
0.01% 240
2021
Q3
$27.4K Sell
631
-26,351
-98% -$1.17M 0.02% 220
2021
Q2
$631K Buy
26,982
+26,351
+4,176% +$1.11M 0.02% 153
2021
Q1
$24.4K Hold
631
0.02% 195
2020
Q4
$22.7K Hold
631
0.02% 182
2020
Q3
$24.1K Hold
631
0.02% 157
2020
Q2
$22.2K Hold
631
0.02% 148
2020
Q1
$20.6K Hold
631
0.03% 127
2019
Q4
$28.5K Hold
631
0.02% 128
2019
Q3
$25.7K Hold
631
0.02% 129
2019
Q2
$27.1K Hold
631
0.02% 127
2019
Q1
$24.2K Buy
+631
New +$24.1K 0.03% 133

Other funds holding BSX

Kelly Financial Services's BSX Position: Q3 2024 in Review

Kelly Financial Services sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 631 shares — an estimated $48.6K sold.

Kelly Financial Services first reported a position in BSX in Q1 2019 and held it in 22 quarters. The position peaked at $631K in Q2 2021. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Kelly Financial Services reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 631 Boston Scientific shares in Q3 2024, an estimated $48.6K.
  • Kelly Financial Services first reported a position in Boston Scientific in Q1 2019 and held it in 22 quarters.
  • Kelly Financial Services's Boston Scientific position peaked at $631K in Q2 2021.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.